Dreyer Scott's Form 4 filing
Collegium Pharmaceutical, Inc (COLL) · filed Mar 24, 2025
- Accession no.
- 0001062993-25-006148
- Filed
- Mar 24, 2025
- Trade date
- Mar 20-21, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $624.8K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Dreyer ScottCIK 0001746251 | Officer (EVP & Chief Commercial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 20, 2025 | Common Stock | SSaleDisposed | −1,927 | $30.00 | −$57,810 | 122,494 | Direct | |
| Mar 21, 2025 | Common Stock | SSaleDisposed | −18,881 | $30.03 | −$566,996.43 | 103,613 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.